Wrap Technologies director gets 100,000 stock options
Wrap Technologies director Bruce Bernstein reported a new stock option grant.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Wrap Technologies director Bruce Bernstein reported a new stock option grant. On February 1, 2026, he received a stock option to buy 100,000 shares of Wrap Technologies common stock at an exercise price of $2.18 per share, expiring on February 1, 2036.
According to the filing, 33,000 options vested immediately on the grant date. The remaining options will vest in three equal annual tranches, as long as Bernstein continues to be employed by or provide services to the company on each vesting date. After this grant, he beneficially owns 100,000 derivative securities directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 100,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. 33,000 of the stock options vested on the date of grant and the remainder will vest ratably in three annual tranches thereafter, provided that the Reporting Person is employed or providing services to the Issuer on the applicable vesting date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Bruce Bernstein report in this Form 4 for WRAP?
What is the exercise price and expiration date of Bruce Bernstein’s WRAP options?
How do Bruce Bernstein’s Wrap Technologies stock options vest?
What is Bruce Bernstein’s role at Wrap Technologies in this filing?
How many derivative securities does Bruce Bernstein own after this WRAP transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.